By keeping food in their stomach longer, the person feels full sooner and for longer, which makes them less likely to overeat
Gastrointestinal Adverse Events GI AEs are the most frequently reported side effects of GLP-1 RAs and, although typically mild, moderate, and transient, they remain the primary reason for treatment discontinuation among individuals with obesity receiving semaglutide [13, 27, 38, 40,41,42,43,44,45,46, 52]
Because semaglutide is a peptide molecule with a molecular weight of 4113 daltons and is over 99% protein bound, the amount in milk is likely to be very low
Patients with obesity or metabolic syndrome who are at risk of kidney complications
The placebo group only saw this in 37% of cases
Tirzepatide is broken down by proteolytic enzymes (it is a peptide), while escitalopram is metabolized by liver enzymes (CYP2C19 and CYP3A4)